Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04993261

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

This trial studies the use of a special type of computed (CT) scan called dual energy CT in detecting gastrointestinal carcinoid tumors. CT is an imaging technique that uses x-rays and a computer to create images of areas inside the body. Dual energy computed tomography is a technique used during routine CT scans to help obtain and process the image after the scan is complete. Doctors want to learn if dual energy computed tomography can help improve the detection of carcinoid tumors during routine CT scans.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Carcinoid Syndrome Adenocarcinoma Carcinoid Tumor Carcinoma Chemically-Induced Disorders Digestive System Neuroendocrine Tumor G1 Drug-Related Side Effects and Adverse Reactions Metastatic Carcinoid Tumor Neoplasms Neoplasms by Histologic Type Neoplasms, Germ Cell and Embryonal Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue Neuroectodermal Tumors Neuroendocrine Tumors Serotonin Syndrome

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

M D Anderson Cancer Center

Houston, Texas, 77030, United States

About this study

PRIMARY OBJECTIVES:

I. Evaluate prospectively the sensitivity and specificity of dual energy computed tomography (CT) in detecting primary gastrointestinal (GI) carcinoid.

OUTLINE:

Patients undergo one dual energy CT scan during scheduled CT scan.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with: clinical features of carcinoid syndrome (or) increased serum and urinary markers suggestive of carcinoid (or) endoscopic biopsy proven carcinoid (or) metastases which are biopsy proven as carcinoid.
  • Patient is scheduled to have a clinically indicated staging CT exam.
  • Patients who have signed their informed consent form to undergo the study.

Exclusion criteria

  • Patients who have already had their primary GI carcinoid resected.
  • Contraindication to intravenous contrast agents (e.g. allergy, renal failure, dialysis, pregnancy etc.).
  • Pregnant patients.

Treatment and study plan

Dual-Energy Computed Tomography

Procedure

Undergo dual energy CT scan

Other names: DECT

Primary outcomes

  1. Sensitivity and specificity of dual energy computed tomography in detecting primary gastrointestinal carcinoid tumors

    Time frame: through study completion, an average of 1 year

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Official study title

Evaluation of Dual Energy CT for the Detection of Gastrointestinal Carcinoids

Important dates

Study start
2015
Primary completion
2026
Study completion
2026
First posted
Aug 6, 2021
Registry last updated
Feb 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.